This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Ironwood Pharmaceuticals, Inc. - Class A (IRWD)

NASDAQ

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) -272.81M -72.62M -64.85M -51.86M
Operating Gains/Losses 610.00K 20.00K 7.00K 474.00K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -1.73M -835.00K 2.24M 2.32M
(Increase) Decrease in Inventories -11.92M -6.70M 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 2.83M -2.35M
(Decrease) Increase In Payables -11.72M 24.24M 5.09M 2.74M
(Decrease) Increase In Other Current Liabilities -2.25M -1.35M -1.13M -4.26M
(Increase) Decrease In Other Working Capital -8.02M -37.32M -45.81M -17.08M
Other Non-Cash Items 21.55M 17.57M 13.97M 4.56M
Net Cash From Continuing Operations -273.36M -69.63M -75.24M -61.93M
Net Cash From Discontinued Operations 0.00 0.00 0.00 -5.97M
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -273.36M -69.63M -75.24M -67.90M
Sale of Property, Plant & Equipment 0.00 9.00K 4.00K 1.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 196.10M 140.76M 222.25M 236.48M
Purchases of Property, Plant & Equipment -9.59M -13.98M -9.68M -17.22M
Acquisitions 0.00 0.00 0.00 9.50M
Purchases of Short-Term Investments -287.94M -96.71M -97.51M -441.80M
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -101.43M 30.08M 115.06M -213.04M
Issuance of Debt 175.00M 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 147.06M 89.25M 3.39M 205.19M
Repayment of Long-Term Debt -768.00K -275.00K -260.00K -1.96M
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -7.72M 0.00 0.00 0.00
Net Cash From Financing Activities 313.58M 88.97M 3.13M 202.96M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents -61.21M 49.42M 42.96M -77.98M
IRWD News

IRWD Ironwood Pharmaceuticals, Inc. - Class A

Analysts Ratings for IRWD

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
GET IRWD ANALYST REPORT

Brokerage Partners

IRWD Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs